Skip to main content

Women May Not Recognize Non-Lump Symptoms of Breast Cancer

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 3, 2023.

By Lori Solomon HealthDay Reporter

FRIDAY, Nov. 3, 2023 -- Fewer than half of women recognize symptoms other than a lump in the breast as a potential sign of breast cancer, according to the results of a survey commissioned by The Ohio State University Comprehensive Cancer Center: The James (OSUCCC-James).

The survey was conducted online (974 participants) and via telephone (30 participants) from Sept. 22 to 24, 2023. Results showed that one-third of women say they are confused about recommendations for breast cancer screenings, particularly those under age 30 (44 percent). Furthermore, just 31 percent of participants recognized a retracted, inverted, or downward-pointing nipple as a symptom of breast cancer, and just 39 percent recognized breast puckering as a symptom. Similarly, fewer than half of participants were aware of loss that breast feeling (41 percent) and pitting/thickening of the breast skin (45 percent) could be symptoms. Just half recognized nipple discharge (51 percent) as a concern worthy of medical attention.

"Screening mammography is our No. 1 defense in detecting and addressing breast cancers at their earliest, most treatable stages, but it is also very important for people to be familiar with the look and feel of their own breast tissue so that sometimes subtle changes can be evaluated quickly to give us the best chance at early detection," Ashley Pariser, M.D., director of breast cancer survivorship services at the OSUCCC-James, said in a statement.

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care

TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.